Loading stock data…
$3.17-0.10 (-3.06%)
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.
Tilray Brands, Inc. in the Healthcare sector is trading at $3.17 with a market capitalization of $636M. Wall Street consensus targets $6.44 (9 analysts), implying a +103.3% move over the next 12 months. The stock is currently near its 52-week low of $3.16, remaining 45.9% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 19 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $281.71M↑ | $206.73M↓ | $217.51M↑ | $209.50M↓ | $224.53M |
| Gross Profit | $90.52M↑ | $54.95M↓ | $57.50M | $57.47M↓ | $67.63M |
| Operating Income | -$4.51M↑ | -$19.87M↑ | -$20.01M↓ | -$10.87M↑ | -$12.66M |
| Net Income | -$49.57M↓ | -$26.57M↑ | -$44.93M↓ | -$322,000↑ | -$1.27B |
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The compan...